Product Details
ACTEMRA, 20MG/ML, (200 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML
Manufacturer: GENENTECH, INC
MFG#: 50242-0136-01
NDC: 50242-0136-01
PID: 634882
Additional Information
| Product Name | Actemra, 20 mg/mL, (200 mg), Single-Dose Preservative-Free Vial, 1x10 mL |
| Active Ingredient | Tocilizumab |
| Mechanism of Action | IL-6 receptor antagonist, reducing inflammation and immune response |
| Concentration | 20 mg/mL |
| Total Dose | 200 mg per vial |
| Formulation | Solution for intravenous infusion |
| Route of Administration | Intravenous (IV) infusion |
| Preparation | Must be diluted in an appropriate IV solution prior to administration |
| Compatibility | Compatible with 0.9% sodium chloride solution for dilution |
| Safety Precautions | Monitor for infections, infusion reactions, neutropenia, and liver enzyme elevations |
| Container Type | Single-dose, preservative-free vial |
| Storage Conditions | Refrigerate at 2°C to 8°C (36°F to 46°F); protect from light, do not freeze or shake |
| Indications | Rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, cytokine release syndrome |
Description
Actemra (Tocilizumab) 20 mg/mL, 200 mg, is a prescription biologic medication available in a single-dose, preservative-free vial containing 10 mL of solution. It is a recombinant humanized monoclonal antibody that targets interleukin-6 (IL-6) receptors, inhibiting the inflammatory response. Actemra is primarily indicated for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, and cytokine release syndrome.
This formulation is designed for intravenous administration, ensuring controlled and effective delivery of the active ingredient. The preservative-free nature of the vial reduces the risk of potential adverse reactions associated with preservatives. Each vial contains 200 mg of tocilizumab in a 10 mL solution, providing a concentration of 20 mg/mL to accommodate weight-based dosing requirements.
Actemra functions by blocking IL-6-mediated signaling pathways, thereby reducing inflammation, joint damage, and systemic symptoms associated with autoimmune diseases. It has been shown to improve clinical outcomes in patients with moderate to severe rheumatoid arthritis who have had an inadequate response to conventional disease-modifying antirheumatic drugs (DMARDs).
Frequently Asked Questions (FAQs)
The cost of ACTEMRA, 20MG/ML, (200 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML is $available for registerd members only
ACTEMRA, 20MG/ML, (200 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML is manufactured by GENENTECH, INC.
You can purchase ACTEMRA, 20MG/ML, (200 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML on our website at https://supplies.pipelinemedical.com/product/detail/actemra-20mg-ml-200-mg-singledose-presrv-free-vial-1x10-ml-634882